Visión generalGráficoNoticiasTraderScreen

UBS Knock-Out AZN/  DE000UM6PF24  /

UBS Investment Bank
13/11/2024  21:55:46 Diferencia+0.020 Bid- Ask- Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
5.740EUR +0.35% -
Volumen de oferta: -		 -
Tamaño/ Volumen/ Formato de Ask: -		 AstraZeneca PLC 125.3245 USD 31/12/2078 Put
TeleTrader 12/11 Europe closes deep in red amid earnings, data
TeleTrader 12/11 AstraZeneca's revenue in Q3 rises 21% to $13.5B
GlobeNewswire 27/08 Structure Therapeutics Appoints Angus C. Russell to Board of Directors
GlobeNewswire 13/08 Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
TeleTrader 25/07 AstraZeneca's Q2 revenue up by 13% to $12.94B
GlobeNewswire 20/06 Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Gr...
GlobeNewswire 12/06 Connect Biopharma Announces New Leadership and Chair of the Board of Directors
TeleTrader 20/05 AstraZeneca to build $1.5B plant in Singapore
GlobeNewswire 15/05 Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire 13/05 Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08/05 Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
TeleTrader 25/04 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 01/04 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent ...
GlobeNewswire 28/03 Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
GlobeNewswire 25/03 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, In...
GlobeNewswire 25/03 Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
GlobeNewswire 19/03 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Phar...
TeleTrader 19/03 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 15/03 American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...
TeleTrader 14/03 AstraZeneca to acquire Amolyt Pharma for $1.05B
GlobeNewswire 29/02 Kidney Month: 31 Day of Action to Equip and Empower People to Fight Kidney Disease
GlobeNewswire 28/02 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
TeleTrader 19/02 Europe closes mostly flat with eyes on earnings, data
TeleTrader 12/02 US opens mostly lower with CPI in focus
TeleTrader 08/02 Europe closes mostly higher following earnings